X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2141) 2141
Publication (123) 123
Book Chapter (25) 25
Book Review (17) 17
Conference Proceeding (16) 16
Book / eBook (15) 15
Newspaper Article (14) 14
Dissertation (1) 1
Trade Publication Article (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1645) 1645
male (983) 983
index medicus (825) 825
female (806) 806
urology & nephrology (730) 730
middle aged (682) 682
dialysis (557) 557
adult (522) 522
aged (480) 480
kidney failure, chronic - therapy (465) 465
hemodialysis (451) 451
renal dialysis (425) 425
peritoneal dialysis (421) 421
pharmacology & pharmacy (378) 378
animals (374) 374
pharmacokinetics (356) 356
dialysis solutions - pharmacokinetics (321) 321
nephrology (217) 217
rats (199) 199
time factors (196) 196
kidney failure, chronic - metabolism (195) 195
renal dialysis - methods (194) 194
ultrafiltration (194) 194
peritoneum - metabolism (192) 192
treatment outcome (172) 172
peritoneal dialysis, continuous ambulatory (167) 167
kinetics (154) 154
models, biological (148) 148
glucose - pharmacokinetics (147) 147
protein binding (145) 145
analysis (136) 136
dialysis solutions - chemistry (135) 135
transplantation (134) 134
medicine & public health (130) 130
care and treatment (129) 129
adolescent (126) 126
prospective studies (125) 125
aged, 80 and over (117) 117
peritoneal dialysis - methods (117) 117
mortality (116) 116
research (116) 116
biological transport (115) 115
permeability (113) 113
patients (112) 112
absorption (111) 111
health aspects (111) 111
kidney diseases (111) 111
therapy (110) 110
metabolism (107) 107
kidney failure, chronic - complications (105) 105
plasma (104) 104
risk factors (104) 104
chronic kidney failure (102) 102
dose-response relationship, drug (102) 102
hemodialysis-patients (101) 101
kidney failure, chronic - blood (101) 101
renal dialysis - adverse effects (100) 100
drugs (99) 99
child (94) 94
medicine (91) 91
metabolic clearance rate (91) 91
pharmacology/toxicology (91) 91
equilibrium dialysis (90) 90
failure (90) 90
dialysis solutions (89) 89
half-life (89) 89
membranes, artificial (86) 86
rats, sprague-dawley (86) 86
chronic kidney-disease (85) 85
hematology (85) 85
chromatography, high pressure liquid (84) 84
pharmacology (84) 84
capd (83) 83
dialysis solutions - analysis (83) 83
glucose (83) 83
renal replacement therapy (83) 83
administration, oral (82) 82
dialysis patients (81) 81
toxicology (81) 81
renal dialysis - instrumentation (80) 80
transport (80) 80
capd patients (78) 78
clearance (78) 78
blood (76) 76
follow-up studies (75) 75
pediatrics (75) 75
area under curve (74) 74
microdialysis (74) 74
icodextrin (73) 73
internal medicine (73) 73
acute kidney injury - therapy (72) 72
engineering, biomedical (72) 72
injections, intravenous (72) 72
kidney failure, chronic - physiopathology (71) 71
proteins (71) 71
dialysis solutions - administration & dosage (70) 70
diffusion (70) 70
hydrogen-ion concentration (69) 69
blood proteins - metabolism (68) 68
peritoneal dialysis - adverse effects (68) 68
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2131) 2131
Polish (18) 18
Spanish (15) 15
Japanese (12) 12
German (8) 8
Italian (7) 7
Chinese (4) 4
French (2) 2
Portuguese (2) 2
Croatian (1) 1
Dutch (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Pharmacokinetics, ISSN 0312-5963, 4/2011, Volume 50, Issue 4, pp. 253 - 265
Patients with type 2 diabetes mellitus often have impaired renal function or may have impaired hepatic function, which can pose significant safety and... 
Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | Research-and-development | Antihyperglycaemics, pharmacokinetics | Type-2-diabetes-mellitus | Diabetes-mellitus | Dipeptides, pharmacokinetics | Renal-impairment | Saxagliptin, pharmacokinetics | Haemodialysis | Liver-dysfunction | METFORMIN | THERAPY | CHRONIC LIVER-DISEASE | SAFETY | IMPROVES GLYCEMIC CONTROL | RISK | PHARMACOLOGY & PHARMACY | RANDOMIZED CONTROLLED-TRIAL | Dipeptidyl-Peptidase IV Inhibitors - adverse effects | Hepatic Insufficiency - urine | Dipeptides - pharmacokinetics | Humans | Middle Aged | Hypoglycemic Agents - analysis | Half-Life | Dipeptides - urine | Male | Metabolic Clearance Rate | Adamantane - urine | Adamantane - analysis | Adamantane - blood | Adult | Dipeptidyl-Peptidase IV Inhibitors - analysis | Female | Renal Insufficiency - blood | Hepatic Insufficiency - metabolism | Adamantane - pharmacokinetics | Adamantane - adverse effects | Adamantane - analogs & derivatives | Severity of Illness Index | Hypoglycemic Agents - pharmacokinetics | Dialysis Solutions - chemistry | Dipeptides - adverse effects | Dipeptides - analysis | Renal Insufficiency - metabolism | Renal Insufficiency - urine | Hepatic Insufficiency - blood | Kidney Failure, Chronic - metabolism | Kidney Failure, Chronic - therapy | Dipeptidyl-Peptidase IV Inhibitors - pharmacokinetics | Kidney Failure, Chronic - blood | Aged | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Dipeptides - blood | Renal Dialysis | Complications and side effects | Liver diseases | Physiological aspects | Dosage and administration | Research | Pharmacokinetics | Saxagliptin
Journal Article
Clinical Journal of the American Society of Nephrology, ISSN 1555-9041, 2016, Volume 11, Issue 8, pp. 1377 - 1383
Journal Article
Clinical Pharmacokinetics, ISSN 0312-5963, 4/2011, Volume 50, Issue 4, pp. 245 - 251
Journal Article
Journal Article
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 2/2016, Volume 77, Issue 2, pp. 333 - 338
Journal Article
Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis, 01/2018, Volume 38, Issue 1, p. 73
Journal Article